You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華海藥業(600521.SH):擬以“華海生物”100%股權認購“華奧泰”定向發行的約1.35億股
格隆匯 07-12 19:32

格隆匯7月12日丨華海藥業(600521.SH)公吿,為促進公司生物醫藥板塊的整合與發展,公司董事會於2021年7月12日審議通過了《關於以股權作價向子公司增資的議案》,同意公司以所持有的浙江華海生物科技有限公司(以下簡稱“華海生物”)100%股權作價155,641.15萬元認購公司控股子公司上海華奧泰生物藥業股份有限公司(以下簡稱“華奧泰”)定向發行的13,451.82萬股股份。

該事項完成後,華奧泰股份總數將由30,000萬股增加為43,451.82萬股,註冊資本將由30,000萬元增加至43,451.82萬元;華奧泰將直接持有華海生物100%的股權,公司持有華奧泰的股份將由85.00%增加至89.64%,臨海華海投資管理合夥企業(有限合夥)持有的華奧泰股份將由15.00%減少至10.36%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account